Electronic Records & Electronic Signatures (ERES)

In the initial phase of our scenario, workers on the manufacturing floor reported discrepancies in batch records. Several personnel observed that entries were missing or seemed altered without appropriate audit…

The first step in addressing compliance with 21 CFR Part 11 is recognizing the symptoms that suggest a potential lapse in adherence to regulatory expectations. Common signals include:Click to read…

Errors surrounding electronic records and electronic signatures can manifest through various indicators. Recognizing these symptoms early is crucial for timely intervention. Common signals include:Click to read the full article.

Creating Effective Audit Trails for Electronic Record Integrity The integrity of electronic records is a common concern in pharmaceutical manufacturing and quality assurance. As companies transition to digital solutions, the…

Identifying symptoms associated with electronic signatures and records is crucial for early intervention. Common signals include:Click to read the full article.

During a routine FDA inspection of a sterile manufacturing facility, the inspectors noted several discrepancies in the electronic records system used for batch production documentation. Key symptoms observed included:Click to…

The first signs of issues with user access control in electronic records systems can often be subtle but impactful. Key symptoms include:Click to read the full article.

Identifying the symptoms of ineffective electronic records management is the first step toward implementing corrective actions. Common symptoms include:Click to read the full article.

Steps to Demonstrate Compliance with ERES in LIMS and CDS Platforms In today’s pharmaceutical landscape, maintaining compliance with regulations governing electronic records and electronic signatures is critical. Especially with the…

Identifying signals related to electronic signature delegation is crucial for timely corrective measures. Potential symptoms include:Click to read the full article.

During a standard verification of compliance with GxP regulations, the company discovered several deviations that indicated potential weaknesses in their electronic records management. Symptoms included:Click to read the full article.

Symptoms indicative of issues within hybrid paper and electronic signature workflows may manifest in various ways. Key signals that could prompt investigation include:Click to read the full article.